Judge Jennifer Walker Elrod of the Fifth Circuit is the Chief Judge of the U.S. Court of Appeals for the Fifth Circuit, a George W. Bush appointee who has sat on the court since 2007 and took over as Chief Judge in 2024. The Fifth Circuit hears federal appeals from Texas, Louisiana, and Mississippi, which makes it one of the busiest and most closely watched appellate courts in the country.1U.S. Court of Appeals for the Fifth Circuit Library. Maps of U.S. Courts of Appeals and District Courts Elrod is known for textualist opinions that push back against federal agency power and defend the right to a jury trial.
Background Before the Bench
Elrod graduated magna cum laude from Baylor University in 1988 with a degree in economics, then went to Harvard Law School, where she graduated cum laude in 1992 and served as a Senior Editor for the Harvard Journal of Law & Public Policy.2Federal Judicial Center. Elrod, Jennifer Walker After law school she clerked for Judge Sim Lake on the U.S. District Court for the Southern District of Texas and spent several years in private practice in Houston handling civil litigation, employment, and antitrust matters.
Her trial-court experience is unusually deep for an appellate judge. Before her federal appointment, she served on the 190th District Court in Harris County, Texas, where over six years she presided over more than 200 jury and non-jury trials.2Federal Judicial Center. Elrod, Jennifer Walker President George W. Bush nominated her to the Fifth Circuit in March 2007, and the Senate confirmed her by voice vote that October. She became Chief Judge in 2024.3United States Court of Appeals for the Fifth Circuit. Judges’ Biographies
How She Decides Cases
Elrod reads statutes according to their ordinary meaning at the time they were written and interprets the Constitution based on how its provisions were originally understood. In practice, that means she is less interested in what a legislature might have hoped to accomplish than in what the words on the page actually say. The goal, as she applies it, is to keep judges from substituting their own policy preferences for the choices Congress made.
A recurring concern in her opinions is whether federal agencies have exceeded the authority Congress gave them. She frequently asks whether Congress clearly authorized what an agency is doing, or whether the agency decided on its own to expand its reach. When the answer looks like the latter, she applies the nondelegation doctrine, which requires Congress to lay out a clear guiding principle before handing rulemaking or enforcement power to an agency.4Constitution Annotated. ArtI.S1.5.3 Origin of Intelligible Principle Standard Her opinions also push back against arrangements where executive officials are too insulated from presidential oversight.
She has written about the erosion of the civil jury trial as well. In a 2011 law review article, W(h)ither the Jury? The Diminishing Role of the Jury Trial in Our Legal System, she argued that the Seventh Amendment right to a civil jury trial is being sidelined by administrative proceedings and other procedural mechanisms. That concern has carried into her opinions.
The Jarkesy Decision
The case that best captures Elrod’s approach is Jarkesy v. SEC. The Securities and Exchange Commission had prosecuted a securities fraud case through its own in-house administrative law judges rather than filing in federal court. Writing for the panel, Elrod found three separate constitutional problems with that process.5United States Court of Appeals for the Fifth Circuit. Jarkesy v. SEC, No. 20-61007
She held that routing fraud cases carrying civil penalties through an agency tribunal instead of a federal court deprived defendants of their Seventh Amendment right to a jury trial. She concluded that Congress had handed the SEC the power to choose between in-house proceedings and federal court without providing a meaningful standard to guide that choice, violating the nondelegation doctrine. And she found that statutory protections shielding the SEC’s administrative law judges from removal violated Article II, which requires the president to maintain oversight of executive officers.5United States Court of Appeals for the Fifth Circuit. Jarkesy v. SEC, No. 20-61007
The Supreme Court affirmed in 2024, but only on the Seventh Amendment ground, holding that when the SEC seeks civil penalties for securities fraud the defendant is entitled to a jury trial. The Court expressly declined to address the nondelegation and removal questions, leaving those portions of Elrod’s opinion without Supreme Court endorsement but also without reversal.6Supreme Court of the United States. SEC v. Jarkesy, No. 22-859
Other High-Profile Rulings
Elrod sat on the panel in Missouri v. Biden, a case alleging that federal officials had unconstitutionally pressured social media companies to suppress speech, particularly posts about COVID-19. In September 2023, the panel found that officials in the White House, the Surgeon General’s office, the CDC, and the FBI had likely coerced or significantly encouraged platforms to remove content in ways that violated the First Amendment. The panel upheld a narrowed version of a district court injunction and struck down broader portions as too vague.
The Supreme Court reversed in June 2024, holding that neither the individual plaintiffs nor the state plaintiffs had established standing to seek an injunction. The Court found no concrete link between the plaintiffs’ injuries and the defendants’ conduct sufficient to support the relief sought.7Supreme Court of the United States. Murthy v. Missouri, No. 23-411 The case never reached a merits ruling on the First Amendment question.
In Alliance for Hippocratic Medicine v. FDA, Elrod’s panel took up a challenge to four FDA actions on mifepristone: the drug’s original 2000 approval, regulatory changes in 2016 that loosened prescribing restrictions, a 2019 approval of a generic version, and a 2021 decision to stop enforcing the in-person dispensing requirement. The panel found the challenge to the 2000 approval likely barred by the statute of limitations and found no injury from the 2019 generic approval, but stayed the 2016 amendments and the 2021 non-enforcement decision.8United States Court of Appeals for the Fifth Circuit. Alliance for Hippocratic Medicine v. FDA, No. 23-10362
The Supreme Court unanimously reversed in June 2024, holding that the plaintiffs lacked Article III standing. The Court found that the doctors’ moral and ideological objections to mifepristone did not constitute concrete injury, and that federal conscience laws already protected them from being compelled to participate in procedures they oppose.9Supreme Court of the United States. FDA v. Alliance for Hippocratic Medicine, No. 23-235
Three of Elrod’s most prominent recent cases share a thread. Each was reversed or narrowed by the Supreme Court on standing or threshold grounds, without the Court deciding whether the government conduct at issue was actually lawful. In Jarkesy, the Supreme Court affirmed one of three holdings and sidestepped the other two. In Murthy and Alliance for Hippocratic Medicine, the Court found the plaintiffs never had the right to sue in the first place. The substantive constitutional arguments Elrod advanced remain live legal theories that could resurface in future cases with different plaintiffs.
Chief Judge and Public Writing
As Chief Judge since 2024, Elrod handles administrative oversight of the Fifth Circuit on top of her regular caseload.3United States Court of Appeals for the Fifth Circuit. Judges’ Biographies Her 2011 article in the Washington & Lee Law Review, W(h)ither the Jury?, examined trends that have reduced the frequency of jury trials in both civil and criminal cases, arguing that the shift undermines a constitutional guarantee the framers considered essential to checking government power.10Congress.gov. U.S. Constitution – Seventh Amendment That argument has run through her work on the bench and remains the clearest window into how she thinks about the relationship between courts, agencies, and the Constitution.